* Cibus Inc CBUS.OQ reported quarterly adjusted earnings
of 6
cents per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $-1.59. The mean expectation of three analysts for the
quarter was for a loss of 89 cents per share. Wall Street
expected results to range from -95 cents to -84 cents per share.
* Revenue rose 250.9% to $1.67 million from a year ago;
analysts
expected $611.00 thousand.
* Cibus Inc's reported EPS for the quarter was a loss of
$7.63.
* The company reported a quarterly loss of $179.97 million.
* Cibus Inc shares had risen by 35.0% this quarter and
lost 77.6%
so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 14.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Cibus Inc is
20.00
This summary was machine generated from LSEG data November 8 at
09:46 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.89 0.06 Beat
Jun. 30 2024 -1.14
Mar. 31 2024 -1.12
Dec. 31 2023 -1.43 -12.59 Missed